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ABStRACt
Sedation has been frequently used alongside many surgical interventions under local anaesthetics (LA). In podiatric 
surgery, there is a paucity of literature on the effects of sedation drugs on surrogate measures of patients’ physiological 
signs. General anaesthetic is practised more frequently than sedation assisted local anaesthetic in podiatry. The aim of 
this audit was to analyse blood pressure (BP) and heart rate (HR) against the administration of midazolam.
A retrospective assessment of sedation notes prior to podiatric procedures undertaken during the years 2008/2009 
was performed. BP (systolic/diastolic mm Hg) and heart rate (beats/min) were recorded prior to the administration of 
midazolam and for the first 30 minutes following administration.
Ninety-four consecutive patients (74 women, 20 men) were admitted for podiatric surgery. Ninety-nine interventions 
were performed, with five of the subjects undergoing two procedures. The mean age was 59±13.5 years (21-87) and 
average midazolam administered 2.8±1.3 mg (0.5-8). Average BP prior to midazolam was 148/85 mm Hg and HR 80. 
At 30 minutes assessment BP was 136/80 and HR 71. BP and HR differences were significantly different at p<0.001 
to the reading prior to administration.
The results presented indicate the use of such a drug as an adjunct to LA in a sedation context has favourable 
results.
Keywords: midazolam; sedation; audit; podiatric surgery.
ReSuMeN
La sedación se ha utilizado con frecuencia junto a muchas de las intervenciones quirúrgicas realizadas bajo anestésicos 
locales (AL) . En la cirugía podológica, hay una escasez de literatura sobre los efectos de la sedación ante las señales 
fisiológicas de los pacientes. La anestesia general se practica con mayor frecuencia que la sedación con anestésico 
local en podología . El objetivo de esta estudioa fue analizar la presión arterial ( PA) y frecuencia cardiaca (FC ) en 
contra de la administración de midazolam.
Se realizó una evaluación retrospectiva de las registros de sedación antes de los procedimientos de podología 
llevadas a cabo durante los años 2008/2009 . La PA ( sistólica / diastólica mm de Hg ) y la FC ( latidos / min ) se 
registraron antes de la administración de midazolam y durante los primeros 30 minutos después de la administración .
Noventa y cuatro pacientes ( 74 mujeres, 20 hombres) fueron ingresados  para cirugía podológica . Se realizaron 
Noventa y nueve intervenciones , con cinco de los sujetos sometidos a dos procedimientos. La edad media fue de 59 
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± 13,5 años ( 21-87 ) y la dosis media de midazolam administrado fue 2,8 ± 1,3 mg ( 0,5-8 ) . La media de la PA antes 
de administrar midazolam fue de 148 /85 mmHg y la FC 80. A los 30 minutos la PA era de 136 /80 y la FC 71 . La PA 
y la FC fueron significativamente diferentes con una p < 0,001 para la lectura antes de la administración.
Los resultados presentados indican el uso de este fármaco junto con el anestesico local en un contexto de sedación 
tiene resultados favorables.
Palabras	clave: midazolam; sedación; auditoría; cirugía podológica.
Sumario: 1. Introduction. 2. Acceptance of podiatric surgery in England. 3. Methods. 4. Results. 5. Discussion. 6. 
Conclusion. References.
Referencia	normalizada: Tollafield, D.R., J., Duarte, R., Akinwale, N., Ashford, R.L., Thomasson, S. The benefits of 
reducing anxiety in a Podiatric Surgical Unit in the UK with Midazolam. Rev. Int. Cienc. Podol. 2014; 8(2): 109-118.
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1.	INtRODuCtION
To our knowledge, no publication has covered 
the subject of sedation using midazolam in po-
diatric surgery, despite the growth in podiatric 
surgery in western countries such as the USA, 
the UK and Australia. Because a good deal of 
foot surgery is performed as day case in the 
community, sedation is limited by local regu-
lations. Orthopaedic day surgery admission for 
foot and ankle surgery equally does not appear 
to provide supportive evidence for sedation in 
the UK. In medicine, midazolam as conscious 
sedation is used in otolaryngology, gastro-en-
doscopy for day procedures and catheterisation 
in cardiac cases. 
Midazolam is a benzodiazepam providing 
anxiolysis, sedation and amnesia as its main 
actions. It is unlike diazepam as it is painless 
on intravenous injection. It has a short duration 
of action due to its high lipophilicity, high me-
tabolic clearance and rapid rate of elimination. 
These properties make midazolam well suited 
to be administered for sedation purposes whilst 
undertaking ‘day stay’ procedures utilising LA, 
particularly as recovery is faster than diazepam, 
but it can last significantly longer in the el-
derly1. The closest ‘non-medical’ field to podia-
tric surgery in the UK is undoubtedly dentistry. 
The case for the use of sedation in dentistry and 
indeed podiatric surgery are well founded. It 
has been shown to synergistically complement, 
where appropriate, the use of local anaesthetic 
in former2, and as this paper suggests, procedu-
res carried out by podiatric surgical specialists.
Podiatric surgery is an established specialty 
in the UK accounting for some 65 operative 
day surgery centres. During a period 2010-
2013 over 41,000 patients were recorded un-
der the care of podiatry within England (Data 
source PASCOM-10). Taking data at the time 
of writing (2013) 8% of podiatric procedures 
were carried out under general anaesthetic and 
5% under sedation assisted local anaesthetic. 
Podiatry (including podiatric surgery) is 
regulated by the Health and Care Professions 
Council (HCPC). The sub-specialty of podia-
tric surgery originally arose from Chiropody3 
but more formally as part of a sub group known 
as the Podiatry Association in 1974, which ini-
tially permitted certain nail surgical procedu-
res to be performed under local anaesthetics. 
A rapid expansion of the scope of practice de-
veloped which eventually included bone and 
joint surgery within the foot and its associated 
structures4. The work of these early pioneers 
was performed in small office type theatres 
in the private sector and it wasn’t until 1986 
when the first NHS podiatric surgery units were 
established in Shropshire and Essex that NHS 
recognition was given to this speciality. Histo-
rically, prior to 1974, foot surgery was the sole 
domain of orthopaedic surgeons in the UK with 
the majority of the surgery being performed un-
der general anaesthetic, more often with patient 
overnight admission. With the advent of better 
amide anaesthetic agents and regional blocka-
des, podiatric specialists were able to expand to 
more complex foot and ankle procedures. 
With the establishment of this new sub- spe-
ciality it became necessary to formulate a basic 
framework in which the scope of practice could 
operate. As such, the fundamental principles 
were established which included: securing a 
safe discharge for all patients; appropriate pain 
control pre and post-surgery; and reduction of 
infection risk. Contextually the alignment of 
this framework also dovetailed into the need 
to maintain low waiting times and to provide a 
community based service. NHS funding through 
a new initiative called GP Fundholding provided 
a good cost basis for the provision of NHS work. 
This allowed for better integration of podiatric 
surgery and so increased volume. By 1998 NHS 
podiatric surgery had a firm basis with a number 
of units set up a dedicated theatres in the commu-
nity, and some serviced integrated services into 
acute hospital units. Those that worked within 
the acute hospital setting benefitted from the co-
llaborative services with anaesthetists. By 2003 
(Figure 1) general anaesthetic became more fre-
quent and increased to 50% cases. Meanwhile 
sedation was found helpful in the absence of an 
attendant anaesthetist with fewer than 10% elec-
ting to have local anaesthetic unaided. 
2.	 ACCePtANCe	 OF	 PODIAtRIC	 SuR-
GeRY	IN	eNGLAND
Evidence gathered by Tollafield5 from a selec-
tion of general medical practitioners based in a 
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medium sized UK city demonstrated growing 
support for this fledgling service, which at that 
point existed exclusively in the private sector. 
The current intravenous sedation practice 
commenced in 1995 and has been modified 
over time resulting in a practice similar to that 
recommended by the American Society of 
Anesthesiology (ASA) guidelines for sedation 
and analgesia by non-anaesthetists6,7. The ASA 
guidelines are an accepted scale recognised in-
ternationally as a system for assessing patient’s 
health in respect to safety for anaesthesia. It is 
a 1-5 scale where incremental health changes 
increase the morbidity risk with anaesthetic 
and surgery. With the expansion of the scope of 
practice as described above and with the intro-
duction of sedation into podiatric surgical pro-
cedures, there is a growing need to be able to 
document, and indeed demonstrate experience 
in this area of practice. Therefore the current 
study utilised a selection of data from the most 
widely used database audit system used in the 
UK: the Podiatric Audit in Surgery and Clinical 
Outcome measurement PASCOM8 to illustrate 
the growth of IV sedation in podiatric surgery 
for the first 12 years: 1993-2005 (Figure 1). 
The PASCOM system is well established in the 
UK and is widely used across many of the UK 
podiatric surgical units. A corresponding decli-
ne in local anaesthetic used as a sole agent can 
also be seen in Figure 1. 
The data reported in this paper utilises cross 
sectional audit data of sedation between 2008-
09. As the only podiatric (surgery) centre in the 
UK using the technique up until 2013, without 
an anaesthetist’s direct support (anaesthetic 
sessions are however supported by trained staff 
in the monitoring of patients), the team sought 
information that would allow informed reflec-
tion on the benefits and effects of midazolam 
on known measureable parameters routinely 
used in our theatre. 
Figure	1.	Data for 1993-2005 Walsall Manor Hospital showing growth of sedation (SED) with local anaes-
thetic (solid line) versus local anaesthetic alone (line with diamond) against growth of general anaesthetic 
(GA dashed line). The lines cross where sedation was found to benefit patients in three ways; a) commence-
ment of surgery (knife to skin) appeared faster from the time of injection b) the lowering of blood pressure 
provided a better experience for each patient c) the additional need to top local anaesthetic (LA) up seemed 
to occur less frequently.
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3.	MetHODS
Patients
The sample consisted of 94 consecutive pa-
tients, admitted for podiatric surgery between 
the years 2008 and 2009. During this period 
99 interventions were performed; five of the 
subjects underwent two procedures. Procedu-
res carried out included first ray (osteotomies, 
implants, arthroplasty, arthrodesis), hammer 
toes, neuroma surgery; amputations and mi-
dfoot fusions. Ankle blocks were utilised in 
every patient as this technique allows volumes 
to be delivered to key nerves and ankle tourni-
quet were used in all cases.	Seventy-four of the 
individuals were women (78.7%) and 20 were 
men (21.3%). The mean age was 59 ± 13.5 
years (range 21 - 87). The average body mass 
index (BMI) was 26.8 ± 3.87 kg/m2 (range 20.5 
- 34.1).
A medical questionnaire was completed 
before surgery providing comprehensive in-
formation of the patients’ present medical and 
previous surgical and anaesthetic history, along 
with relevant drug information. Within the ini-
tial consultation; standard urine, blood pres-
sure, pulse and body mass index (BMI) were 
recorded. All patients completed an informed 
consent. The consent form also highlighted 
the fact the service offered did not include re-
gistered medical practitioners. The method of 
anaesthetic administration was discussed with 
each individual patient. This allowed each pa-
tient to make an informed decision as to what 
type of anaesthetic they would prefer. The op-
tions offered included local anaesthetic with or 
without sedation, or general anaesthetic. 
A pre-operative assessment was completed 
prior to the day of surgery in order to act on 
changes to previous medical history. Pre-opera-
tive tests including full blood count, erythrocy-
te sedimentation rate, urea & electrolytes, liver 
function test, and 12 lead electrocardiogram 
(ECG), were performed and reviewed where 
appropriate. ECG monitoring is mandatory for 
sedation while blood tests are performed routi-
nely for patients being considered for general 
anaesthesia but not for local anaesthesia unless 
medical reasons are recognised. 
Sedation
An intravenous cannula sited in one of the arm 
veins was taped securely to prevent movement 
and dislodgement. Saline 0.5ml was used to 
flush the cannula ensuring patency and correct 
positioning. Patients were given midazolam 
intravenously based on their weight, age and 
level of anxiety with doses titrated to effect as 
recommended in the British National Formu-
lary (BNF) section for conscious sedation1. The 
concentration of the drug used was 2mg per 
ml in a total of 5mls i.e. 10mg per ampoule. 
An initial dose of 2 mg was infiltrated IV over 
1-2 minutes with older or frail and underweight 
(low BMI) patients getting a lower dose of 0.5 
– 1 mg. Additional boluses of 0.5-1 mg were gi-
ven if desired effect had not been achieved after 
about 5 minutes. The whole process took about 
10 minutes to complete. Weight was used less 
as a guide rather than the response from slow 
titration. This method of providing a bolus dose 
by titration to effect provides a safer approach 
compared to that done using body weight/ mcg, 
as the total amount of drug used is lower in the 
former. The outcome of the above was to permit 
sufficient consciousness to allow the patient be 
able to talk but feel calm and relaxed. 
The process of anxiolysis is also identified 
with a fall in blood pressure and heart rate. As 
the procedure is carried out without anaesthe-
tist support no additional drugs are combined.
Blood pressure (BP), heart rate (HR), and 
oxygen saturation (SO
2
) were measured. SO
2 
was maintained at >95-97% with a variable 
concentration oxygen mask (MCâ) medium 
concentration receiving oxygen at 4l/min. 
exclusion	criteria
Patients excluded for surgery mirror those for 
sedation at our centre. Criteria for exclusion 
included: obesity; uncontrolled diabetes; high 
smoking levels and undiagnosed hypertension 
(based on three repetitive values of which two 
should be taken at the GP surgery), chronic res-
piratory disease and renal concerns. Children 
(under 16 years) were excluded while patients 
unfit for surgery were referred for further medi-
cal consultation. 
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Data	collection
A retrospective assessment of sedation notes 
prior to podiatric surgeries undertaken during 
the years 2008 and 2009 was performed. De-
mographical data included age, gender and 
BMI. Blood pressure (systolic/diastolic mm 
Hg), heart rate (beats/min) and oxygen satu-
ration (%) were recorded prior to sedation and 
every five minutes following administration of 
midazolam. Sedation was evaluated in five mi-
nute intervals according to the Ramsay sedation 
scale. This is a universally accepted tool used 
to assess levels of sedation in the healthcare 
setting. First used by Ramsey and colleagues in 
1974 it comprises 6 different levels depending 
on how rousable the patient is9. 
The data was collected as part of a retrospec-
tive clinical audit and therefore ethical approv-
al was not required according to institutional 
guidelines and the National Research Ethics 
Service10. No additional procedures were car-
ried out for research purposes. No personal 
medical information or identifiable information 
is presented within the manuscript. Informed 
consent prior to administration of midazolam 
was obtained for all the patients.
Data	analysis
Some of the data did not follow normal distri-
bution and attempts to transform the data were 
not successful. As analysis of variance is robust 
to violations of normality, repeated-measures 
ANOVA were performed to investigate changes 
in blood pressure, heart rate and sedation throug-
hout 30 minutes following administration of mi-
dazolam. Assumption of sphericity was verified 
through Mauchly’s test. If the assumption of 
sphericity was violated, the degrees of freedom 
associated with the analysis was to be corrected. 
Degrees of freedom were corrected using Green-
house-Geisser estimate of sphericity, when the 
variances of the differences between levels were 
significantly different. Changes in blood pressure, 
heart rate and sedation were controlled for gender, 
age, BMI and midazolam dose administered.
To further investigate differences between 
the time points, a Bonferroni correction was 
applied to not inflate type I error probability; 
significance represented p<0.008. Post hoc 
tests were conducted using bootstrapped pai-
red-sample t test based on 10,000 samples.
Data is reported as mean ± standard devia-
tion (range). Statistical significance was judged 
at 5% level except were otherwise mentioned. 
Statistical tests were performed using the Pre-
dictive Analytics SoftWare (version 18.0, SPSS 
Inc., Chicago, IL, USA).
4.	ReSuLtS
The average dose of midazolam administered 
was 2.81 ± 1.28 mg (range 0.5 – 8). Throughout 
the period of time evaluated, oxygen levels ran-
ged from 92% to 100%. Assumption of sphe-
ricity were violated (p < 0.001), therefore the 
degrees of freedom and the p-values presented 
correspond to Greenhouse-Geisser correction. 
Significant differences prior to administration 
of midazolam and at intervals of 5 minutes up 
to 30 minutes were observed for blood pressure 
and heart rate, but not for sedation according to 
the Ramsay scale (Table 1). Following a slight 
increase in sedation between 5 to 10 minutes 
(t(77) = -2.65, p = 0.01), sedation levels remai-
ned constant throughout the time periods.
An initial reduction can be observed for both 
systolic and diastolic blood pressure (Figure 
2) followed by apparent stability, while initial 
heart rate rose slightly followed by a reduction 
and apparent stabilization (Figure 3).
To further investigate these results, analyses 
of the different periods were carried out, with 
significance representing p<0.008 after a Bon-
ferroni correction (Table 2).
Statistically significant differences were ob-
served for systolic blood pressure prior to and 
after 5 minutes and for the interval of 5 to 10 
minutes, while for diastolic blood pressure and 
heart rate, statistically significant differences 
were observed at the 5 to 10 minutes interval. 
Following this time point, significant differen-
ces were not observed in the subsequent inter-
vals for both blood pressure and heart rate, in-
dicating stability.
Gender did not significantly influenced 
blood pressure (p = 0.47 / p = 0.35) or heart 
rate (p = 0.37). Patients’ age did not seem to 
be a contributor to decrease in BP (p = 0.47 / 
p = 0.27) or HR (p = 0.96). Systolic (p = 0.52) 
and diastolic (p = 0.42) BP, and HR (p = 0.71) 
were not significantly influenced by BMI. 
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Before 148.8 ± 19.7 / 85.5 ± 10.1 79.7 ± 15.0 -
5 Minutes 140.7 ± 19.4 / 82.8 ± 10.6 79.9 ± 14.4 1.79 ± 0.6
10 minutes 134.7 ± 16.1 / 78.9 ± 11.2 76.1 ± 13.4 1.95 ± 0.7
15 minutes 133.3 ± 14.1 / 79.4 ± 10.1 74.9 ± 13.8 1.95 ± 0.6
20 minutes 132.9 ± 16.9 / 78.3 ± 11.2 74.3 ± 12.9 1.93 ± 0.7
25 minutes 135.7 ± 15.2 / 80.0 ± 9.7 73.6 ± 12.9 1.92 ± 0.7
30 minutes 135.4 ± 16.5 / 78.6 ± 10.4 72.9 ± 12.1 1.90 ± 0.7
Test statistic F(3.87, 247.8) = 12.2 / F(4.83, 304.1) = 6.8 F(3.03, 118.2) = 7.57 F(3.23, 228.8) = 1.84
P <0.001 / <0.001 <0.001 0.135
Mean ± standard deviation
table	1.	Changes in blood pressure, heart rate and sedation.
Figure	2.	Mean blood pressure following administration of midazolam. Error bars represent standard deviation.
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Figure	3.	Mean heart rate following administration of midazolam. Error bars represent standard deviation.
	 Blood	pressure	(systolic/diastolic) Heart	rate
Before - 5 Min t(88) = 4.19, p<0.001 / t(88) = 2.46, p=0.01 t(56) = 1.55, p=0.13
5 Min - 10 Min t(92) = 4.23, p<0.001 / t(92) = 3.45, p=0.001 t(89) = 5.69, p<0.001
10 Min - 15 Min t(92) = 0.51, p=0.61 / t(92) = -0.95, p=0.35 t(93) = 1.22, p=0.22
15 min - 20 Min t(92) = 0.32, p=0.76 / t(92) = 1.38, p=0.18 t(93) = 2.32, p=0.02
20 Min - 25 Min t(92) = -1.91, p=0.07 / t(92) = -1.83, p=0.08 t(93) = -0.35, p=0.73
25 Min - 30 Min t(90) = 0.48, p=0.63 / t(90) = 1.55, p=0.13 t(92) = 1.26, p=0.21
A Bonferroni correction indicates p<0.008 as significant
table	2. Five minute interval differences for blood pressure and heart rate.
Midazolam dose significantly contributed to 
a decrease in systolic BP, F(42.6, 247.8) = 
1.514, p<0.05 and diastolic BP, F(53.1, 304.1) 
= 1.708, p<0.005. Midazolam dose contribu-
tion to decrease in HR did not reach statistical 
significance (p = 0.154). Since there were no 
significant differences in sedation according to 
the Ramsay scale, this variable was not con-
trolled for the variables gender, age, BMI and 
midazolam dose.
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5.	DISCuSSION
To our knowledge, there is no literature on 
the isolated effect on patient BP and HR with 
regional ankle blockades with midazolam in 
podiatric surgery. The technique of regional 
ankle blockades remains favoured by podiatric 
surgeons. Midazolam is short lived and wor-
ks best over the first 30 minutes. We collected 
physiological data as part of our routine record 
blood pressure and heart rate, as well as SO
2
 to 
enable us to create a database record of eviden-
ce pertaining to patients from 2008-09. In 94 
cases, patients responded well to reduction in 
HR and BP. SO
2
 was well controlled at all times 
and the review of this cohort did not require any 
medical intervention, peri-operative admission 
or reversal agent. All patients were older than 
20 and none older than 87. Females were seen 
more frequently for podiatric surgery than ma-
les. This can be attributed to a greater aware-
ness of foot pathology and a desire for earlier 
intervention, often co-associated with higher 
footwear expectations demanded by society.
In a number of patients who consented for 
surgery, no self-perceived anxiety was conside-
red and yet evidence showed that blood pressu-
re was elevated from the clinical values. After 
midazolam had been used the blood pressure 
reduced. The general view held by the medical 
profession today is that blood pressure is over 
treated and that we must be cautious over the 
phenomenon of “white coat syndrome” which 
commonly arises when upon admission to hos-
pital or attending a new clinical specialty. Many 
patients are at risk from being sent home when 
presenting for day surgery admission due to the 
misconception that hypertension exists. The use 
of midazolam provides some support that nor-
mal expectations of anxiety can exclude essen-
tial hypertension. In the full cohort of patients 
treated between 1995-2005 only two such cases 
were sent home where blood pressure did not 
responded to IV anxiolysis.
While heart rate is an important indicator 
of release of catecholamines associated with 
anxiety and pain, midazolam was found in this 
study to transiently increase heart rate before 
reducing it. This effect is similar to findings 
from previous studies [11, 12, 13], and could be 
partly attributed to decrease in systemic vascu-
lar resistance caused by midazolam. The reduc-
tion in catecholamines resulting from anxioly-
sis leads ultimately to reduction of heart rate 
and blood pressure. The exact change upon lo-
cal anaesthesia effectiveness cannot be shown 
in this audit and would be better afforded by 
randomised controlled study.
A patient with raised heart rate and blood 
pressure will respond to midazolam but even 
with good quality anaesthesia the clinician and 
sedationist must be aware that a small percenta-
ge of patients respond poorly and state that they 
can feel pain. If after 10 minutes, following an 
additional titre of midazolam up to 5mg with 
additional anaesthetic the patient is still both 
anxious or feels pain, a ‘ten minute rule’ is 
applied. It is more often pointless to continue. 
The patient will need to be scheduled for as-
sisted anaesthetic – general anaesthetic. Nerve 
stimulated blocks can work but are not used 
routinely for the ankle at our centre as they are 
rarely needed.
The results from this study however suggest 
that while our method is safe and potentially 
cost effective in comparison to LA, it does not 
preclude or infer that working with an anaesthe-
tist is not preferred. The reason for such a state-
ment arises to avoid cancellation of cases where 
it is known that a small number may have to be 
converted to full general anaesthetic. The au-
thors’ are not suggesting that sedation is a subs-
titute for general anaesthesia, and highlight the 
increasing trend in the use of general anaesthe-
tics in many hospital based podiatric surgical 
practices. This of course is more closely aligned 
to orthopaedic hospital practice.
6.	CONCLuSION
This study allows a more critical review of the 
effects of midazolam further emphasizing its 
potential value in podiatry surgery. We have 
demonstrated that sedation within controlled 
and well supported environments can afford 
safe use of an intravenous drug by trained staff. 
From experience, time to surgical incision 
appears faster with the use of anxiolysis than 
without. The importance of this feature seems 
more relevant where theatre pathway design in-
volves local anaesthetic administration only in 
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the dedicated anaesthetic room. This contrasts 
with the method of administering local anaes-
thetic blocks on a ward without cannulation, 
monitoring or drug assisted anxiolysis. In the 
latter case blocks administered one hour befo-
re surgery commences are commonly practised 
by podiatric surgical services. The use of Mi-
dazolam in a podiatric surgical context has uti-
lity and does offer an additional adjunct in this 
every expanding sub-speciality.
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